- In a survey of adults with kidney failure who were receiving dialysis, most owned mobile devices and had intermediate or advanced mobile health proficiency.
- The main reasons for using mobile health were for making appointments, communicating with healthcare personnel, and obtaining laboratory results.
Newswise — Washington, DC (December 22, 2020) — In a survey of adults with kidney failure who were receiving dialysis treatments, most patients were proficient in mobile health and willing to use it. The findings come from an analysis that will appear in an upcoming issue of CJASN.
Mobile devices, such as smartphones and tablets, can be used by individuals to access their medical information, track and receive reminders of their appointments and medications, and participate in virtual visits with clinicians. In this way, mobile health can provide many benefits for patients, especially for those with complicated care and dietary restrictions.
“Importantly mobile technology has been used to improve treatment adherence; address patient-reported symptoms in real time; improve nutrition, activity and mental health; assist in empowering patients to reverse the predominantly one-way care delivery system; and place the patient at the center of their own health care,” said Wael Hussein, MD, of Satellite Healthcare.
A limiting factor for healthcare providers and technology developers is whether people on dialysis are ready to use mobile health. Dr. Hussein and his colleagues conducted a survey of adults with kidney disease who were undergoing dialysis to assess the availability of mobile devices and the Internet for such patients, and to get a sense of their proficiency and interest in using mobile health.
A total of 949 patients (632 receiving hemodialysis and 317 receiving home dialysis) across 3 U.S. states completed the survey. Among participants, 81% owned smartphones or other Internet-capable devices, and 72% reported using the Internet. The majority (70%) reported intermediate or advanced mobile health proficiency.
The main reasons for using mobile health were for making appointments (56%), communicating with healthcare personnel (56%), and obtaining laboratory results (55%). The main concern with mobile health was privacy and security (18%).
Mobile health proficiency was lower in older patients, participants with Hispanic/Latinx ethnicity, and those with less than college education. Employment was associated with higher proficiency.
“Mobile health can be utilized to bring along a number of interventions that can help people on dialysis manage their health and improve independence,” said Dr. Hussein. “Findings of our study are encouraging to healthcare providers and technology developers to invest in innovations and solutions that utilize mobile health.
An accompanying editorial notes that applying mobile health to kidney care could benefit from a number of lessons learned from other clinical areas where the use of apps is more widespread.
An accompanying Patient Voice editorial provides the perspective of a patient who has lived with kidney disease for 18 years, noting that “integrating mobile health into the kidney healthcare system will empower patients to embrace taking charge of their health.
Study co-authors include Paul N. Bennett, PhD, Sloane Pace, BSc, Shijie Chen, MPH, Veronica Legg, MS, Jugjeet Atwal, DPrMan, Sumi Sun, MPH, and Brigitte Schiller, MD.
Disclosures: All authors were in the employment of Satellite Healthcare.
The article, titled “The Mobile Health Readiness of People Receiving In-Center Hemodialysis and Home Dialysis,” will appear online at http://cjasn.asnjournals.org/ on December 22, 2020, doi: 10.2215/CJN.11690720.
The editorial, titled, “Mobile Health in Dialysis: The Best Engagement Medium Is The One That’s With Patients,” will appear online at http://cjasn.asnjournals.org/ on December 22, 2020, doi: 10.2215/CJN.18051120.
The Patient Voice editorial, titled, “Patients with Kidney Disease: Ready to Use Smartphones for Health Care Delivery?” will appear online at http://cjasn.asnjournals.org/ on December 22, 2020, doi: 10.2215/CJN.17771120.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries. For more information, visit www.asn-online.org.
# # #
MEDIA CONTACTRegister for reporter access to contact details